MG
Prof. Manoj Garg
Amity University, Cancer Institute, National University of Singapore
0000-0002-3492-2957
Employment
-
Amity University Professor2022 - Present
-
Amity University Associate Professor2018 - 2022
-
Cancer Institute Assistant Professor2016 - 2018
-
National University of Singapore Research Fellow2010 - 2016
-
National Institute of Immunology Research Associate2009 - 2010
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (77)
- Synthesis and potential anticancer activity of 3-(Arylsulfonamido)-N-(pyridin-2/3-yl)benzamide derivatives in pancreatic ductal adenocarcinoma through modulation of AKT/mTOR/STAT3 signalling Save
- Anticancer and therapeutic efficacy of XPO1 inhibition in pancreatic ductal adenocarcinoma through DNA damage and modulation of miR-193b/KRAS/LAMC2/ERK/AKT signaling cascade Save
- Potential role of p53 deregulation in modulating immune responses in human malignancies: A paradigm to develop immunotherapy Save
- Synthesis and Biological Evaluation of vicinal-Diaryl Pyrazole Ethyl Carboxylate Analogs as Antiproliferative Agent against Pancreatic Cancer Save
- Design and Synthesis of Thiazole Scaffold-Based Small Molecules as Anticancer Agents Targeting the Human Lactate Dehydrogenase A Enzyme Save
- Current perspective of transcriptional regulators in human health and diseases Save
- Long non-coding RNAs: Fundamental regulators and emerging targets of cancer stem cells Save
- Arsenicum album Induces Cell Cycle Arrest and Apoptosis, and Inhibits Epithelial–Mesenchymal Transition in Hormone-Dependent MCF7 Breast Cancer Cells Save
- In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies Save
- In-silico design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1,2,3-triazole hybrids as novel EGFR inhibitors targeting lung cancer Save